Literature DB >> 8130995

The value of the short tau inversion recovery sequence in magnetic resonance imaging of thyroid eye disease.

R D Laitt1, B Hoh, C Wakeley, J Kabala, R Harrad, M Potts, P Goddard.   

Abstract

22 patients with thyroid eye disease were examined with magnetic resonance imaging (MRI) and the results compared with 10 controls. Imaging was performed on a 1.0 T scanner using a head coil. All patients were examined using both T1W and short tau inversion recovery (STIR) sequences. The relative signal intensity (SI) of individual extraocular muscles were quantified by comparison with SI from the adjacent temporalis muscle to give a signal intensity ratio (SIR). The results were compared with clinical disease activity assessed by the Werner grading system. Visual evaluation of muscle size and calculated SIRs showed an increase when compared to normals in 15 of the 22 patients. This difference was significant in patients with high grade (4-6) clinical disease. The known histological changes in this disease suggest that this increase in signal is caused by oedema secondary to acute inflammation. STIR sequences suppress the retro-orbital fat and thus enhance these changes both in the muscles and in the fat itself. The MR findings suggest that the STIR sequence can be used to predict those patients that will respond to anti-inflammatory treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8130995     DOI: 10.1259/0007-1285-67-795-244

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  8 in total

1.  Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy--a pilot study at 1.5 T.

Authors:  Eberhard C Kirsch; Achim H Kaim; Marion Gregorio De Oliveira; Georg von Arx
Journal:  Neuroradiology       Date:  2009-09-15       Impact factor: 2.804

Review 2.  Management of strabismus in thyroid eye disease.

Authors:  R Harrad
Journal:  Eye (Lond)       Date:  2014-12-19       Impact factor: 3.775

3.  Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Katsutaro Morino; Satoshi Ugi; Yoshihiko Nishio; Hiroshi Maegawa; Masahito Ohji
Journal:  Jpn J Ophthalmol       Date:  2014-12-03       Impact factor: 2.447

4.  Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy.

Authors:  Y Kaichi; K Tanitame; H Itakura; H Ohno; M Yoneda; Y Takahashi; Y Akiyama; K Awai
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

5.  Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity.

Authors:  Tomoaki Higashiyama; Maki Iwasa; Masahito Ohji
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

6.  Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence.

Authors:  Qian Ge; Xiaohui Zhang; Jian Long; Chun Liu; Lu Wang; Yao Fan; Qian Huang; Ning Yao
Journal:  BMC Endocr Disord       Date:  2021-11-13       Impact factor: 2.763

7.  Current insights of applying MRI in Graves' ophthalmopathy.

Authors:  Cheng Song; Yaosheng Luo; Genfeng Yu; Haixiong Chen; Jie Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

8.  Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Masahito Ohji
Journal:  Clin Ophthalmol       Date:  2016-04-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.